Abstract
Members of the ras gene family code for 21-kDa proteins (p21) located at the inner cellular membrane. Several lines of evidence suggest that p21 proteins are involved in intracellular signal transduction pathways, thus regulating cellular growth and differentiation. Ras proteins bind and hydrolyze GTP (Gibbs et al. 1984; Sweet et al. 1984) and show sequence homology to G proteins (Hurley et al. 1984) which are thought to participate in the action of some cytokines. The p21 of n-ras has been shown to couple receptor binding of hematopoietic growth factors to inositol lipid hydrolysis in fibroblasts (Wakelam et al. 1986). Conversely, activation of G proteins by sodium fluoride in the presence of Al3+ results in expression of cytokines (Yamato et al. 1989), and expression of an activated ras gene transfected into normal cells or cell lines can induce cytokine expression by these cells (Yiagnisis and Spandidos 1987; Demetri et al. 1988; Andrejauskas and Moroni 1989) and change their responsiveness towards growth factors (Kelekar and Cole 1987; Leof et al. 1987). Point mutations leading to an activated p21 occur in numerous human malignancies (for a review, see Bos 1988). Activating mutations of n-ras have been reported to occur in 25%–40% of cases of acute myelogenous leukemia (AML). (Bos et al. 1985; Janssen et al. 1987; Farr et al. 1988). However, the presence of these mutations can be restricted to subpopulations (subclones) of leukemic cells (Toksoz et al. 1987).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andrejauskas E, Moroni C (1989) Reversible abrogation of IL-3 dependence by an inducible H-ras oncogene. EMBO J 8: 2575–2581
Bartram CR, Ludwig WD, Hiddemann W, Lyons J, Buschle M, Ritter J, Harbott J, Fröhlich A, Janssen JWG (1989) Acute myeloid leukemia: analysis of Ras gene mutations and clonality defined by polymorphic x-linked loci. Leukemia 3: 247–256
Begley CG, Metealf D, Nicola NA (1987) Purified colony stimulating factors (G-CSF and GM-CSF) induce differentiation in human HL-60 leukemic cells with suppression of clonogenicity, Int J Cancer 39: 99–105
Bos JL (1988) The RAS gene family and human carcinogenesis. Mutation Res 195: 255–271
Bos JL, Toksoz D, Marshall CJ, Verlaan-de Vries M, Veeneman GH, van der Eb AJ, van Boom JH, Janssen JWG, Steenvorden ACM (1985) Amino-acid substitutions at codon 13 of the N-RAS oncogene in human acute myeloid leukemia. Nature 315: 726–730
Collins S, Groudine M (1982) Amplification of endogenous myc-related DNA sequences in a human myeloid leukemia cell line. Nature 298: 679–681
Dalla-Favera R, Gelman EP, Martinotti S, Franchini G, Papas TS, Gallo RC, Wong-Staal F (1982) Cloning and characterization of different human sequences related to the onco gene (v-myc) of avian myelocytomatosis virus (MC29). Proc Natl Acad Sci USA 79: 6497–6501
Demetri GD, Ernst TJ, Pratt ES, Zenzie BW, Rheinwald JG, Griffin JD (1990) Expression of ras oncogenes in cultured human cells alters the transcriptional and posttranscriptional regulation of cytokine genes. J Clin Invest 86: 1261–1269
Ernst TJ, Gazdar A, Ritz J, Shipp MA (1988) Identification of a second transforming gene, RASn, in a human multiple myeloma line with a rearranged c-myc allele. Blood 72: 1163–1167
Farr CJ, Saiki RK, Erlich HA, McCormick F, Marshall CJ (1988) Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. Proc Natl Acad Sci USA 85: 1629–1633
Feinberg AP, Vogelstein B (1983) A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Ann Biochem 132: 6–13
Gibbs JB, Sigal IS, Poe M, Scolnick EM (1984) Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules. Proc Natl Acad Sci USA 81: 5704–5708
Griffin JD, Young DC, Herrmann F, Wiper D, Wagner K, Sabbath KD (1986) Effects of recombinant human GM-CSF on proliferation of clonogenic cells in acute myeloblastic leukemia. Blood 76: 1448–1453
Hardy KJ, Peterlin BM, Atchinson RE, Stobo JD (1985) Regulation of expression of the human interferon alpha gene. Proc Natl Acad Sci USA 82: 8173–8177
Hirano T, Taga T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatu A, Tsunasawa S, Sakiyama F, Matsui H, Takahara Y, Taniguchi T, Kishimoto T (1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324: 73–75
Hurley JB, Simon MI, Teplow DB, Robishaw JD, Gilman AG (1984) Homologies between signal transducing G proteins and ras gene products. Science 226: 860–862
Janssen JWG, Steenvoorden ACM, Lyons J, Anger B, Bohlke JU, Bos JL, Seliger H, Bartram CR (1987) RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplasia syndromes. Proc Natl Acad Sci USA 84: 9228–9232
Kelekar A, Cole MD (1987) Immortalization by c-myc, H-ras, and Ela oncogenes induces differential cellular gene expression and growth factor responses. Mol Cell Biol 7: 3899–3907
Land H, Parada LF, Weinberg RA (1983) Tumorigenic conversion of primary embryo fibroblast requires at least two cooperating oncogenes. Nature 304: 596–602
Leof EB, Proper JA, Moses HL (1987) Modulation of transforming growth factor type beta action by activated ras and c-myc. Mol Cell Biol 7: 2649–2652
Lübbert M, Mirro Jr J, Kahan J, Miller CW, Isaac G, Kitchingman G, Mertelsmann R, Herrmann F, McCormick F, Koeffler HP (1990) N-ras gene point mutations in childhood acute lymphocytic leukemia correlate with a poor prognosis. Blood 75: 1163–1169
Mallet M, Mane SM, Meltzer S, Needleman SW (1989) C-myc amplification coexisting with N-ras point mutation in the biphenotypic cell line RED-3. Leukemia 7: 511–515
Murray MJ, Cunningham JM, Parada LF, Duatry F, Lebowitz P, Weinberg RA (1983) The HL-60 transforming sequence: a RAS oncogene coexisting with altered myc genes in hematopoietic tumors. Cell 33: 749–757
Noda M, Ko M, Ogura A, Liu DG, Amano T, Takano T, Ikawa I (1985) Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line. Nature 318: 73–75
Olson EN, Spizz G, Tainsky MA (1987) The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol Cell Biol 7: 2104–2111
Oster W, Cicco NA, Klein H, Hirano T, Kishimoto T, Lindemann A, Mertelsmann RH, Herrmann F (1989) Participation of the cytokines Interleukin 6, tumor necrosis factor-alpha, and Interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. J Clin Invest 84: 451–457
Saiki R, Scharf S, Faloona F, Mullis K, Horn G, Erlich HA, Arnheim N (1985) Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230: 1350–1353
Seremetis S, Inghirami G, Ferrero D, Dalla-Favera R (1989) Transformation and plasmacytoid differentiation of EBV-infected human B lymphoblasts by RAS oncogenes. Science 243: 660–663
Sweet RW, Yokoyama S, Kamata T, Feramisco JR, Rosenberg M, Gross M (1984) The product of RAS is a GTPase and the T24 oncogenic mutant is deficient in this activity. Nature 311: 273–275
Toksoz D, Farr CJ, Marshall CJ (1987) ras gene activation in a minor proportion of the blast population in acute myeloid leukemia. Oncogene 1: 409–413
Tomonaga M, Golde DW, Gasson JC (1986) Biosynthetic (recombinant) human granulocyte-macrophage colony stimulating factor: effect on normal bone marrow and leukemic cell lines. Blood 67: 31–36
Wakelam MJO, Davies SA, Houslay MD, McKay I, Marshall CJ, Hall A (1986) Normal p21N-ras couples bombesin and other growth factor receptors to inositol phosphate production. Nature 323: 173–176
Yamato K, El-Hajjaoui Z, Kuo JF, Koeffler HP (1989) Granulocyte-macrophage colony-stimulating factor: signals for its mRNA accumulation. Blood 74: 1314–1320
Yiagnisis M, Spandidos DA (1987) Interleukin-3 like activity secreted from human RAS or MYC transfected rodent cells. Anticancer Res 7: 1293–1298
Yunis JJ, Boot AJM, Mayer MG, Bos JL (1989) Mechanisms of ras mutation in myelodysplastic syndrome. Oncogene 4: 609–614
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Lübbert, M., Oster, W., McCormick, F., Mertelsmann, R., Herrmann, F. (1993). Clonal Analysis of n-ras Gene Activation in Acute Myeloid Leukemia . In: Ludwig, WD., Thiel, E. (eds) Recent Advances in Cell Biology of Acute Leukemia. Recent Results in Cancer Research, vol 131. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84895-7_28
Download citation
DOI: https://doi.org/10.1007/978-3-642-84895-7_28
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84897-1
Online ISBN: 978-3-642-84895-7
eBook Packages: Springer Book Archive